Pharmaceutical Care on A Patient with Low Molecular Weight Heparin Calium-induced Thrombocytopenia
10.3870/j.issn.1004-0781.2017.04.012
- VernacularTitle:1例低分子肝素钙诱导血小板减少症的药学监护
- Author:
Yuan JIANG
;
Guiling SHI
;
Huijuan ZHANG
;
Xiuying SUN
- Keywords:
Low molecular weight heparin calium;
Thrombocytopenia;
Clinical pharmacists;
Pharmaceutical care
- From:
Herald of Medicine
2017;36(4):406-409
- CountryChina
- Language:Chinese
-
Abstract:
Objective To provide reference for clinical pharmacists participating in pharmacotherapy of low molecular weight heparin calium-induced thrombocytopenia.Methods Clinical pharmacists carried out pharmaceutical care for a patient with chronic cor pulmonale with acute exacerbation of chronic asthmatic bronchitis in the use of low molecular weight heparin calium,who developed progressive thrombocytopenia,and helped clinicians to manage adverse reaction and select subsequent treatment drug.Results The suggestions were adopted by clinicians.The platelets of patients gradually recovercd without thrombosis events.Condusion Participation of clinical pharmacists in the treatment of low molecular weight heparin calium induced-thrombocytopenia can effectively improve the prognosis of patients and ensure the safety in drug use.
